Scarica l'app Stockscreener
6.10
2.71%
-0.17
Dopo l'orario di chiusura:
6.10
Precedente Chiudi:
$6.27
Aprire:
$6.11
Volume 24 ore:
248.38K
Relative Volume:
4.16
Capitalizzazione di mercato:
$529.95M
Reddito:
$196.47M
Utile/perdita netta:
$-132.90M
Rapporto P/E:
-3.919
EPS:
-1.5565
Flusso di cassa netto:
$-97.72M
1 W Prestazione:
-3.48%
1M Prestazione:
-44.14%
6M Prestazione:
-46.82%
1 anno Prestazione:
-11.84%
Intervallo 1D:
$6.04
$6.2274
Intervallo di 1 settimana:
$6.04
$6.69
Portata 52W:
$5.4289
$12.25
Valneva Se Adr Stock (VALN) Company Profile
Compare VALN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
6.10 | 529.95M | 196.47M | -132.90M | -97.72M | -1.5565 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-08-03 | Iniziato | H.C. Wainwright | Buy |
Valneva Se Adr Borsa (VALN) Ultime notizie
Valneva's Travel Vaccines: Strategic Pivot to Emerging Markets Drives Long-Term Investor Value in Bi - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Declaration of shares and voting rights of Valneva SE – March 2026 - GlobeNewswire Inc.
Valneva SE Under Investigation for Securities Fraud - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect - ACCESS Newswire
Valneva (NASDAQ:VALN) Shares Gap UpShould You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
VALN stock nosedives on mixed results from Lyme disease vaccine study - MSN
Valneva (NASDAQ:VALN) Sees Large Volume IncreaseHere's Why - MarketBeat
Short Interest in Valneva SE Sponsored ADR (NASDAQ:VALN) Rises By 25.4% - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect - ACCESS Newswire
2026-03-27 | Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:VALN | Press Release - Stockhouse
VLA.PA Stock Price, Quote & Chart | VALNEVA SE (EPA:VLA) - ChartMill
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN - FinancialContent
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study - Yahoo Finance
VALN Shares Plunge Following Uncertain Outcomes in Lyme Disease Vaccine Trial - Bitget
Jefferies reiterates Valneva stock Buy rating after Lyme trial data - Investing.com
HC Wainwright Has Positive Forecast for Valneva Q3 Earnings - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap Down – Here’s Why - Defense World
FY2030 Earnings Forecast for Valneva Issued By HC Wainwright - Defense World
Valneva (NASDAQ:VALN) Shares Gap DownHere's What Happened - MarketBeat
FY2030 Earnings Estimate for Valneva Issued By HC Wainwright - MarketBeat
Earnings call transcript: Valneva SE Q4 2025 sees EPS beat, stock rises - Investing.com Canada
[20-F] Valneva SE Files Annual R... | VALN SEC FilingForm 20-F - Stock Titan
Valneva SE earnings beat by $0.13, revenue topped estimates - Investing.com India
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study - MSN
Valneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Valneva (NASDAQ:VALN) Trading Up 7.1%Here's What Happened - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 5.6%Here's What Happened - MarketBeat
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. By Investing.com - Investing.com Nigeria
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. - Investing.com
Valneva Se Adr Azioni (VALN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):